Drug

PARP 1/2 Inhibitor SC10914 clinical trials

Also written SC10914.

How studies write it

Studies that test it under each name

3 studies that test it; most in 2020 (2)

Studies that test PARP 1/2 Inhibitor SC10914, by start year
Year	Studies
2016	1
2020	2

A phase 1/2 study counts in both.

Each study’s main condition, where its own words name it.

Industry 3 · Other 0

As reviewed, each with the page that says it.

Open first, then newest update. How each study uses PARP 1/2 Inhibitor SC10914 is read from its arms, and is right about nine times in ten.